Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
23.77
-1.88 (-7.33%)
Mar 31, 2025, 10:13 AM EDT - Market open
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $2.67 billion as of March 31, 2025. Its market cap has decreased by -63.10% in one year.
Market Cap
2.67B
Enterprise Value
1.98B
1-Year Change
-63.10%
Ranking
Category
Stock Price
$23.77
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $2.67B, an increase of 3,342.75%. That is a compound annual growth rate of 42.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.88B | -35.79% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |